Z-ENDOXIFEN emerges as a potential treatment for mbc

NO is doing dose escalation trial (phase 1) right now - not recruiting. This is a promising development. I hope it moves through the system quickly. It will be interesting to see if it eventually ends up paired with other therapies. We just need to keep hanging on.

"However, one of the most surprising observations was the prolonged anti-cancer benefit, which in some cases lasted more than two years in women who had progressed on standard anti-estrogen therapies."

I would consider it a miracle to be able to be on an effective anti-estrogen and not chemo.

That's my prayer Deanna that we can string together enough treatments to see the breakthrough!